Search

Maravai LifeSciences Holdings Inc (Class A)

Lezárt

SzektorEgészségügy

8.4 -2.44

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

8.11

Maximum

8.61

Fő mutatók

By Trading Economics

Bevétel

-21M

-24M

Értékesítés

-14M

51M

Egy részvényre jutó nyereség

-0.07

Profit margin

-47.189

Munkavállalók

415

EBITDA

-17M

-5.2M

Ajánlások

By TipRanks

Ajánlások

Vétel

12 hónapos előrejelzés

-16.09% downside

Osztalékok

By Acuity

Következő eredményjelentés

2026. nov. 5.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

-265M

2.1B

Előző nyitás

10.84

Előző zárás

8.4

Hangulat hírek alapján

By Acuity

100%

0%

326 / 340 Rangsor szerint Healthcare

Maravai LifeSciences Holdings Inc (Class A) Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 24. 20:06 UTC

Maravai LifeSciences is declining amid broader market pressures from rising oil prices and geopolitical tensions, despite reaching a session high earlier.

2026. aug. 21. 19:43 UTC

Maravai LifeSciences Holdings Inc is trading higher today, supported by increased investor interest and unusually high trading volume, despite no specific news identified.

2026. aug. 20. 23:11 UTC

Maravai LifeSciences Holdings Inc. shares are trading roughly flat in after-market hours amid mixed market sentiment influenced by recent fluctuations in U.S. Treasury yields.

2026. aug. 19. 23:11 UTC

Maravai LifeSciences Holdings Inc. shares are higher in after-market trading, recovering from an initial dip despite no specific news to explain the movement.

2026. aug. 18. 19:56 UTC

Maravai LifeSciences is trading higher today, recovering from earlier lows, despite broader market pressures and rising Treasury yields amid inflation concerns.

2026. aug. 17. 20:06 UTC

Maravai LifeSciences Holdings Inc is lower today, continuing a decline since Friday. Shares are near the lower end of their one-month range.

2026. aug. 14. 19:16 UTC

Maravai LifeSciences Holdings Inc. shares are lower, retracing from earlier gains amid broader market concerns over a decline in U.S. retail sales.

2026. aug. 11. 20:01 UTC

Maravai LifeSciences Holdings Inc. shares are lower today, continuing a trend of five consecutive daily declines and trading below the 20-day moving average.

2026. aug. 10. 19:46 UTC

News

Maravai LifeSciences reported second-quarter revenue of $51.4 million, but shares are trading lower amid mixed analyst ratings and a continuing decline since Friday.

2026. aug. 7. 20:02 UTC

News

Maravai LifeSciences shares are lower despite Wells Fargo raising the price target to $6.50 following a revenue increase to $51.4 million in Q2.

2026. aug. 6. 23:51 UTC

News

Maravai LifeSciences reported second-quarter revenue of $51.4 million, exceeding expectations, but shares are lower in after-market trading amid a cautious full-year outlook.

2026. aug. 3. 19:46 UTC

Maravai LifeSciences Holdings Inc shares are lower during Monday's session, trading below their 20-day moving average with no specific news to explain the decline.

2026. júl. 31. 19:36 UTC

Maravai LifeSciences Holdings Inc. shares are lower today amid broader market volatility, having previously dropped to a session low before partially recovering.

2026. júl. 30. 16:56 UTC

Maravai LifeSciences Holdings Inc shares are gaining amid broader market recovery, with the S&P 500 advancing as investors engage in bargain hunting.

2026. júl. 29. 20:09 UTC

Maravai LifeSciences Holdings Inc shares declined during Wednesday's session, pulling back from earlier gains amid broader market volatility and rising oil prices.

2026. júl. 28. 18:06 UTC

Maravai LifeSciences Holdings Inc is gaining during Tuesday's session, though it pulled back from earlier highs amid broader market pressure in the tech sector.

2026. júl. 24. 19:36 UTC

Maravai LifeSciences Holdings Inc shares are lower amid broader market pressures, reflecting declines in the Nasdaq 100 following disappointing earnings from major tech companies.

2026. júl. 23. 09:01 UTC

Maravai LifeSciences Holdings Inc. shares are lower in pre-market trading, continuing a decline since Wednesday's close without significant recovery.

2026. júl. 22. 19:56 UTC

Maravai LifeSciences Holdings Inc. shares are lower today, retracing from earlier highs amid no specific company news. The stock remains above its 20-day moving average.

2026. júl. 21. 19:56 UTC

News

Maravai LifeSciences' TriLink BioTechnologies secures a patent for CleanCap® technology in China, boosting confidence in RNA-based therapies. Shares are higher since Monday's close.

2026. júl. 20. 20:02 UTC

Maravai LifeSciences Holdings Inc shares are lower amid broader market declines. The stock hit a session low earlier but has since recovered slightly.

Társak összehasonlítása

Árváltozás

Maravai LifeSciences Holdings Inc (Class A) Előrejelzés

Célár

By TipRanks

-16.09% elmozdulás lefelé

12 hónapos előrejelzés

Átlag 7.25 USD  -16.09%

Magas 8 USD

Alacsony 6.5 USD

3 Wall Street elemző 12 hónapos célárain alapulva a(z)Maravai LifeSciences Holdings Inc (Class A) termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

3 ratings

2

Vétel

1

Tartás

0

Eladás

Hangulat

By Acuity

326 / 340 Rangsor szerint Egészségügy

Hangulat hírek alapján

Nagyon erős bearish bizonyíték

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Maravai LifeSciences Holdings Inc (Class A)

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as custom enzyme development and manufacturing and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody, and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California.
help-icon Live chat